the present invention provides compositions and methods for lowering plasma lp levels in humans . the present invention provides compositions and methods for lowering the risk factors for cardiovascular diseases . moreover , this invention provides therapeutic alternatives to current pharmaceutical interventions for the lowering of cholesterol , ldl - cholesterol , triglycerides and other metabolic risk factors .